CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 280 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537 | -25.7% | 5,323 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $723 | +30.7% | 5,323 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $553 | +17.2% | 5,323 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $472 | -99.9% | 5,323 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $427,000 | -16.3% | 5,323 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $510,000 | -2.5% | 5,323 | +51.1% | 0.00% | 0.0% |
| Q1 2022 | $523,000 | -39.7% | 3,523 | -42.5% | 0.00% | -25.0% |
| Q4 2021 | $868,000 | -11.8% | 6,123 | -18.6% | 0.00% | -20.0% |
| Q3 2021 | $984,000 | -4.8% | 7,523 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,034,000 | +38.4% | 7,523 | +31.5% | 0.01% | +25.0% |
| Q1 2021 | $747,000 | +16.5% | 5,723 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $641,000 | +42.4% | 5,723 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $450,000 | -45.4% | 5,723 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $824,000 | – | 11,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |